Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,083.00    -2.00 (-0.18%)
Bid:
1,088.00
Ask:
1,089.50
Spread: 1.50 (0.138%)
Market Cap: £3.89b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Director/PDMR Shareholding

26 Jun 2017 17:21

RNS Number : 2097J
Burberry Group PLC
26 June 2017
Β 

Burberry Group plc (the "Company") - Director/PDMR Shareholdings

Β 

The Company announces that on 26 June 2017 Julie Brown, a director of the Company, decided to waive 75% (94,860 shares) of the Executive Share Plan award she was granted on 30 January 2017 ("ESP 2016/17") due to the overlap of the 2016/17 performance period and 47,099 of nil cost options she was granted on 30 January 2017 (the "buy-out award") in the light of the vesting outcome of her 2014 award from her former employer. The Remuneration Committee welcomed and agreed with her decision.

Β 

The surrender caused the ESP 2016/17 nil-cost options to immediately lapse in respect of 94,860 shares. Julie continues to hold nil-cost options over the balance, being 31,620 shares under the ESP 2016/17.

Β 

Additionally, the surrender caused the buy-out award nil-cost options to immediately lapse in respect of 47,099 shares. Julie continues to hold nil-cost options over the balance, being 167,901 shares, which will vest (subject to continued employment) as follows:

Β 

Β· On 22 July 2017 - 38,901 shares;

Β· On 22 July 2018 - 64,500 shares;

Β· On 22 July 2019 - 64,500 shares.

The Company has also today disclosed on its website (www.burberryplc.com) within the Corporate Governance section) additional information relating to the assessment of performance for 2016/17 in respect of Christopher Bailey's 2014 Exceptional Performance-Based Award.

26 June 2017

The following disclosures are made in accordance with Article 19.3 of the EU Market Abuse Regulation 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Julie Brown

2

Reason for the notification

a)

Position/status

Chief Operating and Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Burberry Group plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.05Β pence each

Β 

Β 

GB0031743007

b)

Nature of the transaction

Surrender (for nil consideration) of nil-cost options over:

(i) 94,860 shares that were granted on 30 January 2017 under the Executive Share Plan; and

(ii) 47,099 shares that were granted on 30 January 2017 as compensation for the incentives Julie Brown forfeited on leaving her previous employer.

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

Nil

94,860

Nil

47,099

Β 

d)

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Aggregate Price

Aggregate Volume

Aggregate

Total

Nil

141,959

Nil

e)

Date of the transaction

2017-06-26

Β 

f)

Place of the transaction

Outside a trading venue

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHLLFLRRAIRFID
Date   Source Headline
3rd Oct 20197:00 amRNSTransaction in Own Shares
2nd Oct 20197:00 amRNSTransaction in Own Shares
1st Oct 20194:45 pmRNSTotal Voting Rights
1st Oct 20197:00 amRNSTransaction in Own Shares
30th Sep 20197:00 amRNSTransaction in Own Shares
27th Sep 20197:00 amRNSTransaction in Own Shares
26th Sep 20197:00 amRNSTransaction in Own Shares
25th Sep 20197:00 amRNSTransaction in Own Shares
24th Sep 20197:00 amRNSTransaction in Own Shares
23rd Sep 20197:00 amRNSTransaction in Own Shares
20th Sep 201910:17 amRNSBoard Changes
20th Sep 20197:00 amRNSTransaction in Own Shares
19th Sep 20197:00 amRNSTransaction in Own Shares
18th Sep 20197:00 amRNSTransaction in Own Shares
17th Sep 20197:00 amRNSTransaction in Own Shares
16th Sep 20197:00 amRNSTransaction in Own Shares
13th Sep 20197:00 amRNSTransaction in Own Shares
12th Sep 20197:00 amRNSTransaction in Own Shares
11th Sep 20197:00 amRNSTransaction in Own Shares
10th Sep 20197:00 amRNSTransaction in Own Shares
6th Sep 20196:05 pmRNSShare Repurchase Programme
2nd Sep 20192:59 pmRNSBlock listing Interim Review
2nd Sep 201911:58 amRNSTotal Voting Rights
8th Aug 20195:31 pmRNSDirector/PDMR Shareholding
6th Aug 20194:35 pmRNSDirector/PDMR Shareholding
6th Aug 201912:50 pmRNSDirector/PDMR Shareholding
1st Aug 201912:09 pmRNSTotal Voting Rights
1st Aug 201910:32 amRNSDirector/PDMR Shareholding
17th Jul 201912:48 pmRNSResult of AGM
16th Jul 20197:00 amRNSFirst Quarter Trading Update
1st Jul 20191:07 pmRNSTotal Voting Rights
24th Jun 201910:15 amRNSDirector/PDMR Shareholding
19th Jun 201911:50 amRNSDirector/PDMR Shareholding
5th Jun 20191:04 pmRNSAnnual Financial Report
3rd Jun 201910:20 amRNSTotal Voting Rights
20th May 20192:30 pmRNSDirector/PDMR Shareholding
16th May 20191:30 pmRNSBoard Changes
16th May 20197:00 amRNSPreliminary Results
1st May 201912:37 pmRNSTotal Voting Rights
1st Apr 201911:33 amRNSTotal Voting Rights
1st Mar 20194:15 pmRNSBlock listing Interim Review
1st Mar 201911:28 amRNSTotal Voting Rights
6th Feb 20194:55 pmRNSBoard Committee Changes
5th Feb 20192:45 pmRNSDirector/PDMR Shareholding
1st Feb 20193:34 pmRNSTotal Voting Rights
28th Jan 20196:07 pmRNSDirector/PDMR Shareholding
28th Jan 201910:00 amRNSDirector/PDMR Shareholding
23rd Jan 20197:00 amRNSThird Quarter Trading Update
2nd Jan 201911:32 amRNSTotal Voting Rights
6th Dec 20183:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.